Fig. 2.
Inhibition of murine myometrial contractions by cromakalim. (A) Cromakalim (5 µM) completely inhibited spontaneous contractions of murine myometrium in a glibenclamide-sensitive manner. (B) Cromakalim (20 µM) completely inhibited OXT (10 nM)-induced phasic contractions in a glibenclamide-sensitive manner. Data are summarized in (C) and (D).